Published in
Elsevier, Journal of Biological Chemistry, 8(288), p. 5353-5356, 2013
Links
- ORCID
- Elsevier
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Derivation of Human Induced Pluripotent Stem Cells from Patients with Maturity Onset Diabetes of the Young
Journal article published in 2013 by
Adrian K. K. Teo,
Rebecca Windmueller,
Bente B. Johansson 
,
Ercument Dirice,
Pal R. Njolstad,
Erling Tjora,
Helge Raeder,
Rohit N. Kulkarni
,
Ercument Dirice,
Pal R. Njolstad,
Erling Tjora,
Helge Raeder,
Rohit N. Kulkarni
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Background: Human induced pluripotent stem cells (hiPSCs) can be harnessed for development of novel therapeutics for metabolic disorders.